Profil
Jana Jensen is currently the Director at Adaptive Phage Therapeutics, Inc. and also holds a current position as Chief Operating Officer at Deerfield Discovery & Development LLC.
She holds an MBA from Rutgers State University of New Jersey and a doctorate from the University of Kansas.
Postes actifs de Jana Jensen
| Sociétés | Poste | Début |
|---|---|---|
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies for bacterial infections | Directeur/Membre du Conseil | 29/06/2021 |
Deerfield Discovery & Development LLC
Deerfield Discovery & Development LLC Pharmaceuticals: MajorHealth Technology Engages in drug discovery activities | Directeur des opérations | - |
Formation de Jana Jensen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Kansas
University of Kansas Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Adaptive Phage Therapeutics, Inc.
Adaptive Phage Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops therapies for bacterial infections | Commercial Services |
Deerfield Discovery & Development LLC
Deerfield Discovery & Development LLC Pharmaceuticals: MajorHealth Technology Engages in drug discovery activities | Health Technology |
















